The coronavirus disease 2019 (COVID-19) pandemic is a rapidly evolving scenario that is changing the medical landscape. Real-time reverse transcription–polymerase chain reaction of nasopharyngeal swab (NPS) specimens is the preferred method of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing.1 However, blind NPS testing poses risk to patients with sinus pathology. Sinus and skull-base surgery frequently removes bony partitions between the nasal cavity and skull base, resulting in the exposure of critical neurovascular structures. After surgery, patients are theoretically at higher risk of cerebrospinal fluid leak and neurovascular damage during NPS insertion.2 In fact, recent reports illustrate the risk of cerebrospinal fluid leak caused by NPS insertion during SARS-CoV-2 testing.3
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Accepted for Publication: December 17, 2020.
Published Online: March 4, 2021. doi:10.1001/jamaoto.2020.5663
Corresponding Author: Philip G. Chen, MD, Department of Otolaryngology–Head and Neck Surgery, University of Texas Health San Antonio, 7703 Floyd Curl Dr, MC 7777, San Antonio, TX 78229 (firstname.lastname@example.org).
Author Contributions: Mr Fish and Dr Issa had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Fish, Issa, Jang.
Critical revision of the manuscript for important intellectual content: All authors.
Administrative, technical, or material support: All authors.
Supervision: All authors.
Other—supplied references and helped develop figures: Levine.
Conflict of Interest Disclosures: Dr Levine reported receiving grants from the National Institute on Deafness and Other Communication outside the submitted work. Dr Chen reported receiving consulting fees from Medtronic, Stryker, and Integra outside the submitted work. No other disclosures were reported.
Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.
You currently have no searches saved.
You currently have no courses saved.